Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Four University of Oxford researchers have been awarded prestigious European Research Council (ERC) Starting Grants, each worth €1.5 million for a period of up to five year

Oxford spires. All Souls and Radcliffe Camera

The ERC is the premier European funding organisation for excellent frontier research. Their Starting Grants, part of the Horizon Europe programme, are designed to support exceptional researchers at the beginning of their careers to develop ambitious ideas, build their own teams and establish their independence at a pivotal stage in their careers. This year, the scheme attracted a record 4,807 proposals, with just 421 (8.8%) of these being funded.

Among the awarded scientists, one is from the Medical Science Division:

Dr Andrea Luppi (Department of Psychiatry). Despite decades of research, our understanding of brain function remains fragmented, making it difficult to connect discoveries across different disorders, treatments and especially different species. Dr Luppi will use the ERC Starting Grant to develop a new ‘functional coordinate system’ for the brain: a common language to describe the full complexity of how brain regions act and interact across cognition, disorders, drugs and brain stimulation. The project will combine brain imaging across species and development of advanced computer models, with the goal to unlock insights overlooked by traditional methods, and accelerate how fundamental discoveries in other species can translate to humans.

Congratulations to all the awardees!

Read the full story on the University of Oxford website.

Similar stories

The Nuffield Department of Women's & Reproductive Health's Clinical Research Group recruits its 2,000th participant to the Generation Study

Oxford’s Clinical Research Group (CRG) has reached an important milestone after recruiting its 2,000th participant to the nationwide Generation Study.

Dementias Platform UK (DPUK) blood biomarker project takes next step towards NHS dementia diagnosis

A project involving researchers from the Universities of Oxford and Cambridge, Imperial College London and Dementias Platform UK (DPUK) has been selected for a major UK initiative aimed at improving dementia diagnosis and helping more people access the support and treatment they need sooner.

Robotic hip and knee surgery fails to cut overall risk of repeat surgery

Two major studies from the University of Oxford, Queen Mary University of London and the University of Bristol, have found that robotic-assisted hip and knee replacement does not reduce the overall early risk of repeat surgery compared with conventional surgery.

Oxford medical student takes AI safety message to the Palace of Versailles

Oxford medical student Julian Shellard has presented at an international workshop on the future of Artificial Intelligence (AI) at the Palace of Versailles in Paris, highlighting the important role medical students can play in global conversations on shaping the future of science and medicine.

Everyday DNA damage reveals a hidden weakness in some cancers

Researchers in the Chapman Group at the MRC Weatherall Institute of Molecular Medicine, have discovered why cancer cells lacking a protein called ATM are particularly vulnerable to a class of cancer drugs known as PARP inhibitors, solving a scientific puzzle that has challenged researchers for nearly 20 years.

Dunn School publishes new children’s book to mark centenary

The collaboration with Oxford University Press brings the story of the development of Penicillin to a new audience